Trial Profile
Investigation of the intra-individual variability in exposure and pharmacological effect of rivaroxaban in total joint arthroplasty patients
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions; Pharmacokinetics
- 29 Nov 2016 New trial record